SCHEMBL500470

SCHEMBL500470

CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3C[C@H](CNC4CC4)[C@H](F)C3)cc21

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 1/20 0.59
KDM4E B2RXH2 8/20 0.58
ALDH1A1 P00352 6/20 0.58
HTT P42858 5/20 0.58
HPGD P15428 4/20 0.58
HSD17B10 Q99714 4/20 0.58
LMNA P02545 3/20 0.58
TSHR P16473 2/20 0.58
BRD4 O60885 1/20 0.58
CYP2J2 P51589 1/20 0.58
NPSR1 Q6W5P4 1/20 0.58
MEN1 O00255 7/20 0.57
KMT2A Q03164 7/20 0.57
NPC1 O15118 1/20 0.57
USP2 O75604 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
HIF1A Q16665 1/20 0.52
GAA P10253 2/20 0.51
MAPK1 P28482 1/20 0.50
RAD52 P43351 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL500471 1.00 DRD3 (0.59) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL502106 1.00 DRD3 (0.59) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL500553 0.91 ALDH1A1 (0.59) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL500552 0.91 ALDH1A1 (0.59) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL499945 0.87 ALDH1A1 (0.45) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL499944 0.87 ALDH1A1 (0.45) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL500700 0.87 ALDH1A1 (0.45) DRD3KDM4EALDH1A1HTTHPGD
SCHEMBL500757 0.87 KDM4E (0.59) KDM4EALDH1A1HTTHPGDHSD17B10
SCHEMBL500758 0.87 KDM4E (0.59) KDM4EALDH1A1HTTHPGDHSD17B10
SCHEMBL500376 0.86 ALDH1A1 (0.49) DRD3KDM4EALDH1A1HTTHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1666477-B1 7-(4-SUBSTITUTED 3- CYCLOPROPYLAMINOMETHYL-1- PYRROLIDINYL) Q UINOLONECARBOXYLIC ACID DERIVATIVE KYORIN SEIYAKU KK (JP) 2013-07-03 EP disclosed
US-8106072-B2 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2012-01-31 US disclosed
US-20090176824-A1 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field ASAHINA YOSHIKAZU 2009-07-09 US disclosed
US-7514451-B2 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2009-04-07 US disclosed
US-20060281779-A1 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative KYORIN PHARMACEUTICAL CO., LTD. (JP) 2006-12-14 US disclosed
EP-1666477-A1 7-(4-SUBSTITUTED 3- CYCLOPROPYLAMINOMETHYL-1- PYRROLIDINYL) Q UINOLONECARBOXYLIC ACID DERIVATIVE Kyorin Pharmaceutical Co., Ltd. (JP) 2006-06-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176824-A1 7- (4-substituted-3-cyclopropylaminomethyl-1-pyrrolidinyl) quinolonecarboxylic acid derivative technical field CLPP, PRSS1, FOSB DRD3 1450/4885KDM4E 1507/4885ALDH1A1 2406/4885
US-20060281779-A1 7-(4-Substituted-3-cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative RPS27L, RPS7, RPSA DRD3 1169/4885KDM4E 1345/4885ALDH1A1 2601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.